FindTrial
Sign In

Serum GGT as a Marker of Kidney Involvement in Type 2 Diabetes Mellitus

Association between serum gamma glutamyl transferase and albuminuria in type 2 diabetes mellitus patients. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/12/099660
Enrollment
100
Registered
2025-12-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E112- Type 2 diabetes mellitus with kidney complications

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

Department of medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients diagnosed with type 2 diabetes mellitus as per 2018 guidelines

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
To correlate GGT with UACR with glycemic control , with renal function parameters and comparison of ggt with various grades of albuminuria.Timepoint: Single time point (Baseline)—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Tushar Garg

Sri Guru Ram Das University of Health Sciences , Amritsar

ankuramba@yahoo.co.in9814290885

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026